BusinessERYTECH Announces Filing of 2017 “Document de Référence” and 2017 Annual Report on Form 20-FBy Nasdaq OMXApr 24, 2018, 8:30 PM UTC
BusinessERYTECH to Present Results from Phase I Trial of eryaspase in ALL and New Pre-clinical Data at AACR 2018By Nasdaq OMXApr 12, 2018, 5:30 AM UTC
BusinessCellular Biomedicine Group (CBMG) Approved to Commence Phase I Trial (CALL-1) for C-CAR011 in Adult Patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia (ALL) in ChinaBy Nasdaq OMXJan 9, 2017, 11:11 AM UTC
BusinessEQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against The Allstate Corporation - ALLBy Nasdaq OMXDec 23, 2016, 9:51 PM UTC
